What is myxomatous mitral valve disease?
A gradual, age-related thickening and degeneration of the heart's mitral valve that prevents it from sealing completely, causing a murmur and, over time, potential heart failure.
Quick answer
What is myxomatous mitral valve disease?
A gradual, age-related thickening and degeneration of the heart's mitral valve that prevents it from sealing completely, causing a murmur and, over time, potential heart failure.
Of all the ways a Shar-Pei's heart can develop problems, this aging valve disease is the one most owners will actually encounter if their dog lives into its senior years.

Owners of Shar-Peis age seven and older, particularly anyone whose vet has mentioned a new or worsening heart murmur at a recent exam.
This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.
Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.
Myxomatous mitral valve disease is a gradual, age-related degeneration of the heart's mitral valve, described as the most common cardiac diagnosis in the Chinese Shar-Pei. A formal staging system helps cardiologists determine the right time to start treatment, since starting certain medications before symptoms appear but after structural changes are confirmed can meaningfully delay progression to heart failure.
MMVD is specifically described as the most common heart condition affecting this breed, making it the cardiac diagnosis most Shar-Pei owners are statistically likely to encounter if their dog lives into its senior years.
While MMVD is a widely documented condition across many dog breeds generally, its status as the most common heart issue specifically noted for the Chinese Shar-Pei suggests a meaningful breed-level predisposition, consistent with the breed's broader pattern of health issues linked to its narrow genetic founder history.
Untreated high blood pressure, excess body weight, and general cardiovascular strain from a sedentary lifestyle can all accelerate how quickly valve degeneration progresses to symptomatic heart failure once it begins.
Schedule prompt evaluation for a new or worsening cough, especially at night, faster or labored breathing at rest, reduced stamina, or a swollen abdomen. These can indicate progression to heart failure and need timely staging and treatment adjustment rather than a wait-and-see approach.
Start here: Chinese Shar-Pei Most Common Genetic Disorders: Screening
See all Chinese Shar PEI health problems, which breeds are prone to myxomatous mitral valve disease mmvd, or the full Chinese Shar PEI breed guide for temperament, exercise needs and ownership costs.
MMVD typically progresses over years rather than months in its earlier stages, though the pace varies significantly between individual dogs. Once heart failure develops, ongoing management becomes a more active, closely monitored process.
Success looks like catching structural changes at the earliest stage through imaging, starting appropriate medication at the right time, and maintaining stable heart function and comfortable activity levels for as long as possible.
The mitral valve sits between the heart's left atrium and left ventricle, and its job is to snap shut completely with each heartbeat so blood only flows in one direction. In myxomatous valve disease, the valve's tissue gradually thickens and becomes less pliable, developing small nodular changes along its edges that prevent it from sealing completely. This lets a small amount of blood leak backward with every beat, the source of the murmur a vet hears through a stethoscope, and over years that leak tends to worsen as the degeneration progresses. The heart compensates initially by enlarging somewhat to handle the extra workload, but that compensation eventually reaches its limits, at which point fluid can start backing up into the lungs, the point at which a dog develops the breathing changes and cough associated with heart failure.
Veterinary cardiologists use a staging system, often referenced as the ACVIM classification, that breaks MMVD progression into distinct stages from a detectable murmur with no structural heart enlargement, through structural changes without symptoms yet, to active heart failure with fluid buildup and, eventually, advanced disease that's harder to manage. This staging matters enormously for treatment timing, since starting certain medications at the right stage, once structural heart enlargement is confirmed via echocardiogram even before symptoms appear, has been shown in research to meaningfully delay progression to full heart failure. This is exactly why a murmur alone shouldn't just be tracked passively year after year without imaging: knowing which stage a Shar-Pei's MMVD has reached is what actually determines whether it's time to start medication now or continue monitoring a bit longer.

If you think your Chinese has myxomatous mitral valve disease (mmvd), the plan is three steps: write down what you have seen and when it started, book a veterinary appointment rather than waiting for the next flare, and take video of the behaviour or symptom before you go — the thing you are worried about rarely happens in the consulting room. Screening in the parents covers skin fold dermatitis, entropion, familial shar-pei fever.
What the vet visit should produce is a diagnosis and a written plan, not just reassurance: what is being ruled out, what the monitoring interval is, and which signs mean you come back sooner. Ask what the treatment costs across a year rather than per visit, because that is the number that decides whether you are managing this condition or reacting to it.
Between appointments, keep a short log — dates, what you saw, what changed. It is the single most useful thing an owner brings to a follow-up, and for myxomatous mitral valve disease (mmvd) it is often what separates a clear pattern from a guess.
Samson, an eleven-year-old Shar-Pei in Charlotte, had a known soft murmur that his vet had tracked for years without much concern. When his owner mentioned a new cough that seemed worse at night, his vet moved quickly to a full echocardiogram rather than just listening again. Imaging showed his heart had enlarged meaningfully since the murmur was first detected, placing him at a stage where starting heart failure medication made sense right away rather than waiting further. Samson started daily medication, and within a couple of weeks his cough had eased noticeably and his energy improved.
Key takeaway: A murmur tracked passively for years finally got the imaging it needed once a new symptom appeared, and starting treatment at the right stage, rather than waiting even longer, gave Samson real, fairly quick relief.
It's described as the most common cardiac diagnosis in Chinese Shar-Peis, consistent with it being one of the most frequently diagnosed heart conditions across aging dogs of many breeds generally.
The valve tissue gradually thickens and develops small nodular changes with age, preventing it from sealing completely and allowing blood to leak backward with each heartbeat, a process not fully understood but strongly linked to aging.
It's a classification system cardiologists use to describe MMVD progression, from an early murmur with no structural changes through active heart failure, helping guide exactly when to start specific treatments.
Research has shown starting certain medications once structural heart enlargement is confirmed via echocardiogram, even before symptoms appear, can meaningfully delay progression to heart failure, which is why staging through imaging matters more than symptoms alone.
A persistent cough, especially at night, faster or labored breathing at rest, reduced stamina, and a swollen abdomen are signs that fluid may be backing up, indicating the disease has progressed to active heart failure.
No, it's a progressive degenerative disease that's managed rather than cured, with medication aimed at slowing progression and managing symptoms once they develop, for the remainder of the dog's life.
Recheck frequency depends on the specific stage, ranging from annual monitoring for early, mild disease to every few months once structural changes or symptoms are present.
A gradual, age-related thickening and degeneration of the heart's mitral valve that prevents it from sealing completely, causing a murmur and, over time, potential heart failure.
Yes, it's described as the breed's most frequently diagnosed cardiac condition, consistent with its prevalence across aging dogs broadly.
Starting certain medications at the right stage, once structural changes are confirmed via echocardiogram, can meaningfully delay progression to heart failure.
Ongoing cardiology monitoring plus daily medication once treatment starts adds a genuine recurring cost, generally continuing for the rest of the dog's life.
Yes, many dogs live comfortably for years with appropriate staging and treatment, particularly when medication starts at the right stage rather than only after symptoms appear.
A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.
You get: Vet visit prep sheet
No spam. One-click unsubscribe. See our privacy policy.
Preview page 1 before you decide.





